{"transactions":[{"id":991075,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2025-11-21T21:35:48.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock award was granted under the Company's 2023 Equity Incentive Plan as of November 18, 2025 (the \"Date of Grant\"), based on a closing price of $4.14 per share on such date; the shares vest in full on the one year anniversary of the Date of Grant."}],"balance_after":295000,"source":{"system":"sec-edgar","filing":"0001493152-25-024659","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000149315225024659/ownership.xml","form_type":"4"}},{"id":1060603,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-20T23:54:48.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 18, 2025, with the first vesting occurring on November 18, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":4000,"derivative":{"exercise_price":2.32,"expiration_date":"2035-08-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950170-25-110531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025110531/ownership.xml","form_type":"4"}},{"id":1060602,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President of Finance"}}],"security":"Common Stock","published_at":"2025-08-20T23:54:48.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":10775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10775,"source":{"system":"sec-edgar","filing":"0000950170-25-110531","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025110531/ownership.xml","form_type":"4"}},{"id":1127254,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-06-02T21:30:31.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of May 29, 2025 (the \"Date of Grant\"), based on a closing price of $5.05 per share on such date."}],"balance_after":235000,"source":{"system":"sec-edgar","filing":"0001641172-25-013287","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225013287/ownership.xml","form_type":"4"}},{"id":1163769,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-04-29T10:28:56.000Z","date":"2025-04-24","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were granted under the Company's 2023 Equity Incentive Plan and were fully vested as of April 24, 2025 (the \"Date of Grant\"), based on a closing price of $0.84 per share on such date."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001641172-25-006566","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000164117225006566/ownership.xml","form_type":"4"}},{"id":1186882,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-01T20:05:12.000Z","date":"2025-03-29","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from March 29, 2025, with the first vesting occurring on June 29, 2025 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3000,"derivative":{"exercise_price":1.46,"expiration_date":"2035-03-28","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000950170-25-048491","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025048491/ownership.xml","form_type":"4"}},{"id":1431672,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-16T20:35:36.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-sixteenth of the shares underlying the option vest in equal quarterly installments measured from August 14, 2024, with the first vesting occurring on November 14, 2024 subject to the Reporting Person's continued service through each vesting date."}],"balance_after":1500,"derivative":{"exercise_price":2.42,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000950170-24-098103","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017024098103/ownership.xml","form_type":"4"}},{"id":2281694,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Options","published_at":"2022-05-04T12:30:27.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the employment agreement, the executive was granted a stock option to acquire 25,000 shares of common stock with respect one twentieth of such shares on each of the twenty quarterly anniversaries of the last date of each quarter commencing June 30, 2022."}],"balance_after":25000,"derivative":{"exercise_price":0.41,"exercise_date":"2022-05-02","expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-012011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315222012011/ownership.xml","form_type":"4"}},{"id":2384699,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2022-02-18T21:28:23.000Z","date":"2022-02-15","kind":"sale","acquired":false,"shares":19285,"price":0.58,"value":11185.3,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-22-004963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315222004963/ownership.xml","form_type":"4"}},{"id":2763309,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-01T15:38:40.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":19285,"price":2.87,"value":55347.95,"ownership":{"direct":true},"balance_after":19285,"source":{"system":"sec-edgar","filing":"0001493152-21-007665","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315221007665/ownership.xml","form_type":"4"}},{"id":3036206,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-08T14:52:50.000Z","date":"2020-07-24","kind":"other","acquired":false,"shares":19285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person voluntarily returned the above shares of common stock to the company for cancellation."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-20-017379","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315220017379/ownership.xml","form_type":"4"}},{"id":3146735,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-15T18:00:30.000Z","date":"2020-04-18","kind":"grant","acquired":true,"shares":3571,"price":5,"value":17855.0,"ownership":{"direct":true},"balance_after":3571,"source":{"system":"sec-edgar","filing":"0001493152-20-009016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315220009016/ownership.xml","form_type":"4"}},{"id":3146734,"issuer":{"id":7645,"kind":"organization","name":"Sadot Group Inc."},"owners":[{"id":24475,"kind":"person","name":"Groenewald Ferdinand","position":1,"cik":"0001734018","reported_name":"Groenewald Ferdinand","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-05-15T18:00:30.000Z","date":"2020-04-18","kind":"grant","acquired":true,"shares":15714,"price":5,"value":78570.0,"ownership":{"direct":true},"balance_after":19285,"source":{"system":"sec-edgar","filing":"0001493152-20-009016","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701756/000149315220009016/ownership.xml","form_type":"4"}}]}